General Information of Drug (ID: DM0BAHV)

Drug Name
E-0116
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Phase 3 [1]
Cross-matching ID
TTD ID
D0V8GT

References

1 Biopharmaceutical Research Companies Are Developing Nearly 300 Medicines to Treat Diseases of the Skin. MEDICINES IN DEVELOPMENT FOR Skin Diseases 2011.